Synlett 2009(6): 978-980  
DOI: 10.1055/s-0028-1088209
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Expeditious Stereoselective Synthesis of l-Iminosugar Precursors via a Mitsunobu Reaction

Antoine Bussière, Véronique Barragan-Montero*, Khalid Oumzil, Jean-Yves Winum, Jean-Louis Montero*
Institut des Biomolécules Max Mousseron (IBMM) UMR 5247 CNRS-UM1-UM2 Bâtiment de Recherche Max Mousseron, Ecole Nationale Supérieure de Chimie de Montpellier, 8 Rue de l′Ecole Normale, 34296 Montpellier Cedex, France
Fax: +33(4)67144343; e-Mail: jean-louis.montero@univ-montp2.fr; e-Mail: vbarragan@univ-montp2.fr;
Further Information

Publication History

Received 19 December 2008
Publication Date:
16 March 2009 (online)

Abstract

An efficient stereoselective synthesis of l-imino-C-gulosides is disclosed. Starting from the 2,3:4,6-di-O-isopropylidene-d-mannopyranose the synthetic pathway involves first a Wittig reaction with CMPP to introduce the carbon at the pseudo-anomeric position, followed by a Michael reaction under ultrasound activation to introduce the nitrogen center, and finally a Mitsunobu reaction for the ring closure leading to the C-iminosugar from the l-series.

24

Synthesis of Compound 2
To a solution of 2,3:4,6-Di-O-isopropylidene-d-manno-pyranose (1 equiv, 23 mmol, 6 g) in anhyd benzene was added(cyanomethylene) triphenylphosphorane (3 equiv, 69 mmol, 21 g). The mixture was stirred and refluxed under argon atmosphere for 3 h. The reaction mixture was diluted with CH2Cl2 (200 mL) and washed twice with brine (50 mL). The organic layer was dried over anhyd Na2SO4 for 30 min and concentrated under vacuum to give pale yellowish oil. The crude was chromatographed on SiO2 (PE-Et2O, 5:5) to afford the two isomers (6.5 g, 70% for Z-isomer) as colorless oils. R f  = 0.16 (Z-isomer, major), 0.08 (E-isomer, minor; PE-Et2O, 5:5). ¹H NMR (400 MHz, acetone-d 6):
δ (Z-isomer) = 6.81 (dd, J 1-7 = 11.26 Hz, J 1-2 = 8.00 Hz, H1), 5.77 (dd, J 7-1 = 11.27 Hz, J 7-2 = 1.30 Hz, H7), 5.16 (dt,
J 2-1 = 7.85 Hz, J 2-3 = 7.80 Hz, J 2-7 = 1.27 Hz, H2), 4.72 (dd, J 3-2 = 7.48 Hz, J 3-4 = 1.45 Hz, H3), 4.29 (d, J OH-5 = 6.01 Hz, -OH), 3.81-3.70 (m, H5, H6a), 3.58 (dd, J = 10.16, 9.07 Hz, H6a), 3.48 (dd, J 4-5 = 9.17 Hz, J 4-3 = 1.43 Hz, H4), 1.48, 1.41, 1.37, 1.31 (4 s, 12 H, H10, H11, H13, H14). ¹³C NMR (100 MHz, acetone-d 6): δ (Z-isomer) = 153.45 (C1), 117.16 (C8), 111.70 (C9), 102.34 (C7), 99.90 (C12), 77.87 (C2), 77.64 (C3), 74.44 (C4), 66.48 (C6), 63.94 (C5), 30.09, 27.90, 26.89, 19.96 (C10, C11, C13, C14). MS (ESI+): m/z = 306.22 [M + Na]+.

31

Typical Procedure for the Synthesis of Compounds 3-5
Compound 2 (1 equiv) was dissolved in dry amine in excess. The mixture was placed in an ultrasound bath under an argon atmosphere for 10 h. The unreacted amine was removed under reduced pressure and the byproducts removed by flash chromatography on SiO2 (PE-Et2O, 8:2) to afford compounds 3, 4, or 5 as colorless oils in 80% yield.
Compound 3: R f  = 0.11 (PE-Et2O, 8:2). ¹H NMR (400 MHz, acetone-d 6): δ = 7.46-7.19 (m, 5 H, Hc, Hd, He), 4.48 (dd, J 3-2 = 6.29 Hz, J 3-4 = 1.55 Hz, H3), 4.28 (dd, J 2-1 = 8.85 Hz, J 2-3 = 6.29 Hz, H2), 4.22 (d, J OH-5 = 5.88 Hz, OH), ν0 = 3.82 (ABq, 2 H, νA = 4.03, νB = 3.87, Δν = 64.2 Hz, J AB = 14.0 Hz, Ha), 3.79-3.68 (m, H5, H6a), 3.63-3.50 (m, H6b), 3.61 (dd, J 4-5 = 8.93 Hz, J 4-3 = 1.57 Hz, H4), 3.33 (ddd, J 1-2 = 8.92 Hz, J 1-7b = 5.18 Hz, J 1-7a = 4.49 Hz, H1), 2.81 (dd, J 7a-7b = 17.39 Hz, J 7a-1 = 4.44 Hz, H7a) 2.58 (dd, J 7b-7a= 17.40 Hz, J 7b-1 = 5.29 Hz, H7b), 1.48, 1.33, 1.23, 1.20 (4 s, 12 H, H10, H11, H13, H14). ¹³C NMR (100 MHz, acetone-d 6): δ = 142.55 (Cb), 130.07 and 129.87 (2 C, Cc, Cd), 128.55 (Ce), 119.67 (C8), 110.31 (C9), 99.82 (C12), 80.65 (C2), 75.79 (C3), 74.44 (C4), 66.48 (C6), 63.92 (C5), 53.73 (C1), 52.16 (Ca), 29.98, 27.75, 27.20, 20.03 (4C, C10, C11, C13, C14), 22.03 (C7). MS (ESI+): m/z = 391.13 [M + H]+, 413.13 [M + Na]+. MS (ESI-): m/z = 425.46 [M + Cl]-.
Compound 4: R f  = 0.28 (Et2O). ¹H NMR (400 MHz, acetone-d 6): δ = 4.48 (dd, J 3-2 = 6.26 Hz, J 3-4 = 1.56 Hz, H3), 4.20 (dd, J 2-1 = 8.53 Hz, J 2-3 = 6.26 Hz, H2), 3.84-3.67 (m, H4, H5, H6a), 3.64-3.56 (m, H6b), 3.28 (ddd, J 1-2 = 8.52 Hz, J 1-7b = 5.54 Hz, J 1-7a = 4.52 Hz, H1), 2.73 (dd, J 7a-7b = 17.31 Hz, J 7a-1 = 4.53 Hz, H7a), 2.55 (dd, J 7b-7a = 17.32 Hz, J 7b-1 = 5.54 Hz, H7b), 2.78-2.70 (m, H9a), 2.68-2.61 (m, H9b), 1.49-1.32 (m, H10, H11), 1.50, 1.48, 1.33, 1,32 (4 s, 12 H, H14, H15, H17, H18), 0.91 (t, J 12-11a = 7.20, J 12-11b = 7.20 Hz, H12). ¹³C NMR (100 MHz, acetone-d 6): δ = 119.83 (C8), 110.15 (C13), 99.91 (C16), 80.26 (C2), 75.83 (C3), 74.45 (C4), 66.57 (C6), 64.07 (C5), 55.36 (C1), 48.30 (C9), 34.09 (C10), 30.15, 27.75, 27.13, 20.45 (4 C, C14, C15, C17, C18), 21.95 (C11), 15.25 (C12). MS (ESI+): m/z = 357.31 [M + H]+, 379.33 [M + Na]+. MS (ESI-): m/z = 355.36 [M - H]-, 391.28
[M + Cl]-.
Compound 5: R f  = 0.08 (PE-Et2O, 9:1). ¹H NMR (400 MHz, acetone-d 6): δ = 5.90 (dddd, J 10-11 trans  = 17.29 Hz, J 10-11 cis = 10.33 Hz, J = 6.15 Hz, J = 5.19 Hz, H10), 5.25 (qd, J 11 trans -10 = 17.29 Hz, J = 1.80, 1.80, 1.79 Hz, H11 trans ), 5.08 (ddd, J 11 cis -10 = 10.34 Hz, J = 3.42 Hz, J = 1.48 Hz, H11 cis ), 4.48 (dd,
J 3-2 = 6.28 Hz, J = 1.57 Hz, H3), 4.24 (dd, J = 8.68 Hz, J 2-3 = 6.27 Hz, H2), 3.82-3.55 (m, 4 H, H4, H5, H6a, H6b), 3.47-3.29 (m, 3 H, H1, H9a, H9b), 2.75 (dd, J 7a-7b = 17.35 Hz, J = 4.49 Hz, H7a), 2.55 (dd, J 7b-7a = 17.35 Hz, J = 5.41 Hz, H7b), 1.48, 1.32 (2 d, 12 H, H13, H14, H16, H17). ¹³C NMR (100 MHz, acetone-d 6): δ = 139.48 (C10), 119.76 (C8), 116.70 (C11), 110.26 (C12), 99.90 (C15), 80.52 (C2), 75.85 (C3), 74.52 (C4), 66.54 (C6), 63.96 (C5), 53.15 (C1), 51 (C9), 30.16, 27.74, 27.74, 20.34 (C13, C14, C15, C17), 22.26 (C7). MS (ESI+): m/z = 341.27 [M + H]+, 363.29 [M + Na]+.

32

Typical Procedure for the Synthesis of Compounds 6-8
Compounds 3, 4, or 5 (1 equiv) and Ph3P (2 equiv) were dissolved in a minimum amount of dry toluene. The mixture was stirred under argon at r.t. DEAD (2 equiv, 2.56 mmol, 1.2 mL) was added dropwise, and the mixture was stirred further 3 h. The crude product was purified by chromatog-raphy on SiO2 (PE-Et2O, 7:3) to afford compounds 6, 7, or 8 in 70% yield.

Compound 6: R f  = 0.2 (PE-Et2O, 7:3); [α]D +5.86 (c 1, HCCl3, 25 ˚C). ¹H NMR (400 MHz, acetone d 6 ): δ = 7.42 (m, 2 H, Hc), 7.30 (m, 2 H, Hd), 7.23 (m, 1 H, He), 4.43 (dd, J 3-4 = 2.5 Hz, J 3-2 = 8.0 Hz, H3), 4.25 (dd, J 4-3 = 2.7 Hz, J 4-5 = 5.6 Hz, H4), 4.23 (dd, J 2-1 = 2.1 Hz, J 2-3 = 8.1 Hz, H2), ν0 = 3.99 (ABq, 2 H, νA = 4.13, νB = 3.85, Δν = 112.3 Hz, J AB = 14.3 Hz, Ha), 3.85 (ddd, J 1-2 = 2.2 Hz, J 1-7b = 7.3 Hz, J 1-7a = 7.4 Hz, H1), 3.38 (dd, J 6a-5 = 6.1 Hz, J 6a-6b = 11.7 Hz, H6a), 3.33 (dd, J 6b-5 = 6.4 Hz, J 6b-5 = 11.8 Hz, H6b), 2.99 (dd, J 7a-1 = 7.7 Hz, J 7a-7b = 17.0 Hz, H7a), 3.00 (ddd, J 5-6a = 6.3 Hz, J 5-6b = 6.4 Hz, J 5-4 = 5.7 Hz, H5), 2.91 (dd, J 7b-1 = 7.2 Hz, J 7b-7a = 17.0 Hz, H7b), 1.61 (s, CH3), 1.38 (d, J = 0.4 Hz, CH3), 1.30 (s, CH3), 1.30 (s, CH3). ¹³C NMR (100 MHz, acetone-d 6): δ = 143.17 (Cb), 130.49, 129.94 (C ortho / meta ), 128.71 (C para ), 120.32 (C8), 110.60 (C9), 101.23 (C12), 75.99 (C3), 73.64 (C4), 65.87 (C2), 63.77 (C6), 56.87 (Ca), 56.15 (C5), 53.49 (C1), 27.67, 27.25, 24.44, 22.68 (C10, C11, C13, C14), 19.81 (C7). MS (ESI+): m/z = 373.32 [M + H]+, 395.28 [M + Na]+, 411.18 [M + K]+, 767.57 [2 M + Na]+.
Compound 7: R f  = 0.6 (PE-Et2O, 8:2); [α]D +6.52 (c 1, HCCl3, 25 ˚C). ¹H NMR (400 MHz, acetone-d 6): δ = 4.38 (dd, J 3-4 = 26.0 Hz, J 3-2 = 8.0 Hz, H3), 4.26 (dd, J 4-3 = 2.6 Hz, J 4-5 = 5.6 Hz, H4), 4.15 (dd, J 2-1 = 2.2 Hz, J 2-3 = 8.0 Hz, H2), 3.78 (dd, J 6a-5 = 6.2 Hz, J 6a-6b = 11.7 Hz, H6a), 3.69 (ddd, J 1-2 = 2.2 Hz, J 1-7a = 7.7 Hz, J 1-7b = 8.4 Hz, H1), 3.56 (dd, J 6b-5 = 6.6 Hz, J 6b-6a = 11.7 Hz, H6b), 3.05 (q, J 5-4 =
J 5-6a = J 5-6b = 6.1 Hz, H5), 2.86-2.64 (m, 4 H, H7a, H7b, H9a, H9b), (s, 3 H, CH3), 1.41-1.20 (m, 4 H, H10a, H10b, H11a, H11b), 1.47, 1.36, 1.33, 1.30 (4 s, 12 H, H14, H15, H17, H18). ¹³C NMR (100 MHz, acetone-d 6): δ = 120.20 (C8), 110.46 (C13), 101.13 (C16), 75.97 (C3), 73.47 (C2), 65.69 (C4), 64.57 (C6), 57.07 (C5), 53.58 (C1), 52.66 (C9), 35.35 (C10), 27.60, 27.08, 24.47, 22.85 (C14, C15, C17, C18), 21.60 (C11), 19.81 (C7), 15.38 (C12). MS (ESI+): m/z = 339.36 [M + H+], 361.26
[M + Na]+, 699.47 [2 M + Na]+.
Compound 8: R f  = 0.28 (PE-Et2O, 8:2); [α]D +8.34 (c 1, HCCl3, 25 ˚C). ¹H NMR (400 MHz, acetone-d 6): δ = 5.76 (dddd, J 10-11 trans  = 17.19 Hz, J 10-11 cis  = 10.07 Hz, J 10-9b = 7.99 Hz, J 10-9a = 4.40 Hz, H10), 5.15 (dtd, J 11 trans -10 = 17.21 Hz, J = 2.03 Hz, J 11 trans -11 cis  = 1.11 Hz, H11 trans ), 5.00 (dtd, J 10-11 cis  = 10.07 Hz, J = 1.88 Hz, J 11 cis -9a = 1.87 Hz, J 11 cis -11 trans  = 0.92 Hz, H11 cis ), 4.37 (dd, J 3-2 = 7.94 Hz, J 3-4 = 2.60 Hz, H3), 4.25 (dd, J 4-5 = 5.27 Hz, J 4-3 = 2.60 Hz, H4), 4.17 (dd, J 2-3 = 7.95 Hz, J 2-1 = 2.12 Hz, H2), 3.78 (td, J = 8.17 Hz, J 1-2 = 1.94 Hz, J = 1.94 Hz, H1), 3.74 (dd, J 6a-6b = 11.82 Hz, J = 5.63 Hz, H6a-6b), 3.60 (tdd, J 9a-9b = 14.88 Hz, J 9a-10 = 4.12 Hz, J 9a-11 cis  = 1.87 Hz, J = 1.87 Hz, H9a), 3.57 (dd,
J 6b-6a = 11.76 Hz, J = 5.85 Hz, H6a-6b), 3.26 (tdd, J 9b-9a = 14.88 Hz, J 9b-10 = 7.99 Hz, J = 1.04, 1.04 Hz, H9b), 2.99 (q, J 5-4 = 5.59 Hz, J 5-6a = 5.59 Hz, J 5-6b = 5.59 Hz, H5), 2.84 (d, J = 0.65 Hz, H7a), 2.82 (s, H7b), 1.50, 1.37, 1.34, 1.30 (4 d, 12 H, J = 0.58 Hz, H13, H14, H16, H17). ¹³C NMR (100 MHz, acetone-d 6): δ = 140.93 (C10), 120.04 (C8), 116.88 (C11), 110.53 (C12), 101.04 (C15), 75.88 (C3), 73.75 (C2), 66.04 (C4), 64.51 (C6), 55.81 (C9), 55.67 (C5), 53.38 (C1), 28.07, 27.20, 24.50, 22.38 (C14, C13, C16, C17), 19.77 (C7). MS (ESI+): m/z = 323.27 [M + H]+, 345.21 [M + Na]+, 361.20
[M + K]+.